Total error shift patterns for daily CT on rails image-guided radiotherapy to the prostate bed
- Ronaldo Cavalieri†1,
- Hiram A Gay†2Email author,
- Jingxia Liu3,
- Maria C Ferreira4,
- Helvecio C Mota5,
- Claudio H Sibata6 and
- Ron R Allison7
© Cavalieri et al; licensee BioMed Central Ltd. 2011
Received: 28 July 2011
Accepted: 24 October 2011
Published: 24 October 2011
To evaluate the daily total error shift patterns on post-prostatectomy patients undergoing image guided radiotherapy (IGRT) with a diagnostic quality computer tomography (CT) on rails system.
A total of 17 consecutive post-prostatectomy patients receiving adjuvant or salvage IMRT using CT-on-rails IGRT were analyzed. The prostate bed's daily total error shifts were evaluated for a total of 661 CT scans.
In the right-left, cranial-caudal, and posterior-anterior directions, 11.5%, 9.2%, and 6.5% of the 661 scans required no position adjustments; 75.3%, 66.1%, and 56.8% required a shift of 1 - 5 mm; 11.5%, 20.9%, and 31.2% required a shift of 6 - 10 mm; and 1.7%, 3.8%, and 5.5% required a shift of more than 10 mm, respectively. There was evidence of correlation between the x and y, x and z, and y and z axes in 3, 3, and 3 of 17 patients, respectively. Univariate (ANOVA) analysis showed that the total error pattern was random in the x, y, and z axis for 10, 5, and 2 of 17 patients, respectively, and systematic for the rest. Multivariate (MANOVA) analysis showed that the (x,y), (x,z), (y,z), and (x, y, z) total error pattern was random in 5, 1, 1, and 1 of 17 patients, respectively, and systematic for the rest.
The overall daily total error shift pattern for these 17 patients simulated with an empty bladder, and treated with CT on rails IGRT was predominantly systematic. Despite this, the temporal vector trends showed complex behaviors and unpredictable changes in magnitude and direction. These findings highlight the importance of using daily IGRT in post-prostatectomy patients.
External beam radiotherapy (RT) is an adjuvant treatment option for post-prostatectomy pT3 or margin-positive disease (R1), and a salvage option for those with a rising PSA post-operatively. In the adjuvant setting, three prospective randomized trials have shown that post-operative RT significantly reduces the risk of biochemical failure and disease recurrence in pT3 and R1 prostate cancer [1–3].
Intensity modulated radiation therapy (IMRT) is a well established technique for definitive prostate RT and can reduce acute and late toxicity [4, 5]. It has been utilized for the salvage or adjuvant treatment of post-prostatectomy patients [5–7]. Compared to three-dimensional conformal radiotherapy (3D-CRT), IMRT has the capacity of lowering the dose to the bladder especially when it is full . IMRT can also reduce the dose to the rectum compared to 3D-CRT . Small treatment margins may be more sensitive to geometrical uncertainties, including setup deviations and internal organ motion, making geographic miss a matter of concern.
Therefore, it has become increasingly important to employ image guided radiotherapy (IGRT) to minimize the probability of missing the target and/or over treating normal tissues. Recently, a number studies have described the setup shifts and organ motion observed in post-prostatectomy patients using various imaging techniques and intervals [6, 7, 9–13]. Thus far the total number of post-prostatectomy patients analyzed has been small, and further studies are needed to better characterize this patient population. To our knowledge, this is the first study that describes individual daily total error shift patterns in post-prostatectomy patients from a diagnostic-quality CT-on-rails IGRT system.
58 - 77
PSA, median (range) ng/mL
10.1 (3.7 - 46.2)
0.6 (0.1 - 2.8)
The patients received RT as an adjuvant treatment within 6 months after surgery in the presence of high risk pathologic factors, or salvage therapy more than 6 months post-prostatectomy when there was evidence of biochemical failure. The median interval from surgery to RT was 3.6 months for adjuvant RT patients, and 29 months for salvage treatment patients.
The planning CT was obtained with a 3 mm slice thickness and the patient in the supine position. Patients were instructed to have an empty bladder and rectum for the planning CT. Subsequently, during the course of treatment, bladder and rectal filling was variable with no specific instructions given to the patient. The immobilization system consisted of a neck support and a leg sponge (Dual Leg Positioner, CIVCO, Kalon, IA).
The clinical target volume (CTV) was defined as the prostate bed. The prostate bed encompassed the anatomical volume of the resected prostate tissue, including surgical clips, residual seminal vesicles, vesico-urethral anastomosis, periprostatic tissue, bladder neck, and posteriorly to the rectal wall. A clinical correlation with the operative report and final pathology report were always used to assist in defining this volume. The planning target volume (PTV) was generated with a 10 mm margin around the CTV except 7 mm posteriorly to reduce the volume of irradiated rectum. The treatment isocenter was set up and at the time of CT planning approximately at the center of the CTV. Right lateral and anteroposterior digital reconstructed radiographs (DRRs) were generated to show the location of the isocenter. The patient was subsequently brought to the simulation room and under fluoroscopic guidance the DRRs' isocenter was identified. Skin triangulation points were then marked on the patient's skin as guided by the laser coordinate system of the simulator. All of the patients were prescribed a dose of 7560 cGy in 42 fractions to the PTV with a 7 field IMRT technique.
Daily pre-treatment CT images were acquired on a CT-on-rails system (CTVision™, Siemens, Malvern, PA) to visualize the prostate bed and make any necessary adjustments to ensure target coverage. The system consists of a CT scanner and a linear accelerator opposing each other in the treatment vault and sharing the patient couch. The axes were defined as follows: x-axis (negative, right; positive, left), y-axis (negative, caudal or inferior; positive, cranial or superior), and z-axis (negative, anterior; positive, posterior).
The patient's skin marks are aligned to the setup lasers to localize the isocenter. Radiopaque adhesive fiducials 1.5 mm in diameter (Suremark® Markers™, The Suremark Company, Simi Valley, CA) are placed on the patient's skin, and the treatment couch is rotated 180 degrees to obtain the pre-treatment CT scan with a 1.5 mm slice thickness. The treatment couch is rotated back and the patient alignment is verified.
Using the CT on rails software and the radiopaque fiducials on the pre-treatment CT, the radiation therapist defines the location of the isocenter.
The radiation therapist manually fuses the bony anatomy from the planning CT with the pre-treatment CT as the initial coarse adjustment. If the therapist observes that there is a mismatch in the bony fusion due to rotation, the patient is re-positioned and re-scanned. Since the CT fusion software does not display the yaw, pitch or roll angles, the decision to reposition the patient is based on the therapist's experience.
Once the initial bony fusion is acceptable, the therapist makes fine adjustments by visually inspecting the location of the prostatectomy surgical clips and identifying the prostate bed between the bladder and rectum. By using these anatomical and surgical clip visual cues, the therapist further adjusts the isocenter.
Once the isocenter's fine-tuning is complete, the planning CT PTV is overlaid on that day's CT image to ensure adequate target coverage.
If there is doubt regarding the fusion, or if the x-axis, y-axis, and z-axis isocenter shift exceeds 1 cm, the patient's physician is contacted for approval or further adjustments. Once the fusion is deemed acceptable, the isocenter shift in the x-axis, y-axis, and z-axis is obtained from the software. There is no correction of rotation.
After the therapist adjusts the couch in the x, y and z axes, the patient is treated.
The descriptive statistics of x-axis, y-axis and z-axis shifts were calculated. Pearson correlation coefficients were obtained between the x-axis and y-axis, x-axis and z-axis, and y-axis and z-axis daily shifts for each patient. A p value < 0.05 was taken to indicate statistical significance. A univariate analysis (ANOVA) was used to test the x-axis, y-axis and z-axis patient daily shifts, and a multivariate analysis (MANOVA) was used to test the daily shifts in the (x, y), (x, z), (y, z) and (x, y, z) axes. For the MANOVA and ANOVA analyses, a p value < 0.05 corresponded to a systematic error. The data were analyzed with the SAS statistical software (SAS Institute, Cary, NC). Shift errors were classified as random or systematic.
The average error is the average of all measurements in a given direction (LR, CC, or AP), with positive and negative values representing opposite directions as previously defined. The mean magnitude is the average of the absolute values of all the measurements in a given direction. Consequently, mean magnitudes can only be positive numbers, while average errors could be positive or negative.
In the cranial-caudal direction, 9.2% of the scans required no adjustments, 66.1% required a shift of 1 - 5 mm, 20.9% required a shift of 6 - 10 mm and 3.8% required a shift larger than 10 mm (Figure 1b). The distribution had a kurtosis of -0.02, and was negatively skewed with a skewness of 0.19. The standard deviation was 4.7 mm and the mean -1.1 mm.
Finally, in the posterior-anterior direction, 6.5% of the scans required no shifts, 56.8% required a shift of 1 - 5 mm, 31.2% required a shift of 6 - 10 mm, and 5.5% required a shift of 10 mm or more (Figure 1c). The distribution had a kurtosis of 0.52, and was positively skewed with a skewness of 0.63. The standard deviation was 5.3 mm and the mean -2.2 mm.
Pearson correlation coefficients, ANOVA univariate, and MANOVA multivariate x, y and z axis analysis
Pearson Correlation Coefficients
x-axis vs y-axis
x-axis vs z-axis
y-axis vs z-axis
x, y, z axis
Table 2 also shows the F statistics from the univariate analysis (ANOVA) and the F statistics from the multivariate analysis (MANOVA). The ANOVA analysis suggests that the following patients had systematic errors in the following single axes:
x-axis: 2, 6, 7, 9, 11, 16, and 17
y-axis: 1, 2, 4, 5, 7, 9, 12-17
z-axis: 1-4, 6-10, 12-17
The MANOVA analysis suggests that the following patients had systematic errors in the following combination of axes:
x and y axes: 1, 2, 4, 6, 7, 9, 11-13, 15-17
x and z axes: 1-4, 6-17
y and z axes: 1-10, 12-17
x, y, and z axes: 1-4, 6-17
As IMRT has rapid falloff of dose distribution it has become evident that IGRT should be considered a necessity for reproducible tumor targeting and/or sparing of normal tissues. In the post-prostatectomy patient population, Simpson et al. did not report any toxicities greater than grade 2 when using cone-beam computed tomography (CBCT) and onboard imaging IGRT [13, 14]. Ost et al. reported a lower incidence of grade 1 and 2 genitourinary toxicity in their CBCT group compared with their electronic portal imaging device (EPID) group . These studies highlight the value of IGRT in the post-prostatectomy setting.
Comparison of total errors observed in patients receiving postoperative radiotherapy to the prostate
Mean magnitude (mm)
Standard deviation (mm)
Sandhu et al. 7
Ost et al. 12
Simpson et al. 13
Standard deviation (mm)
Schiffner et al. 11
Ost et al. 12
For 11 patients the smallest total error vector displacement was in the x axis, and the rest were equally divided between the y and z axes. For 12 patients the largest total displacement was in the z-axis, for 3 it was in the y-axis and for 2 in the x-axis.
Figure 3a shows that the cumulative vectors mostly pointed in the caudal and anterior directions. This could be explained by the direction of the forces exerted by the bladder and rectum. Pinkawa et al. has described decreasing bowel and rectal volumes during the course of treatment from urinary and bowel urgency . Similarly, constipation or urinary retention that resolve or start during the course of treatment could further alter the direction of the forces exerted by the bladder and rectum, and account for some of the pattern changes observed during the course of treatment.
None of the patients had average vectors pointing in both the cranial and posterior direction. One potential explanation is that while the patients were instructed to have an empty bladder and rectum for simulation, there was no departmental policy to tell patients to keep an empty bladder or rectum during treatment. Compared to the empty bladder and rectum planning CT, random rectal and bladder filling during treatment may have predominantly pushed the prostate bed anteriorly and/or posteriorly and caudally, respectively.
There was evidence of correlation between the x and y, x and z, and y and z axes in 3, 3, and 3 of 17 patients, respectively. Consequently, for the majority of patients there was no correlation between the axes (Table 2). Univariate (ANOVA) analysis showed that the pattern was random in the x, y, and z axis for 10, 5, and 2 of 17 patients, respectively (Table 2). Therefore, in the cranial-caudal (y-axis) and anterior-posterior (z-axis) directions systematic errors were more common, while in the right and left direction (x-axis) random errors were more common. Furthermore, multivariate (MANOVA) analysis showed that (x,y), (x,z), (y,z), and (x, y, z) errors were random in 5, 1, 1, and 1 of 17 patients, respectively (Table 2). The multivariate analysis suggests that errors were predominantly systematic.
One limitation of this study is that only the total error was analyzed, while other studies also determined the magnitude of the prostate bed motion and the setup error. Both Schiffner and Sandhu et al. reported that the prostate bed motion error was smaller than the setup error [7, 11]. Both the setup error and prostate bed motion errors may be subject to both random and systematic components which vary from patient to patient. Other limitations are that intrafraction motion was not analyzed, the initial and subsequent daily filling of the bladder and rectum in the planning CT was not assessed, and the potential interobserver variability in performing the planning and daily CT fusion was not evaluated. Carefully documenting changes in urinary urgency, urinary retention, and diarrhea during treatment, whether these were treatment related or not, could have helped to further understand the total error patterns. Although we simulated most patients with low volumes of urine in the bladder, we recommend that patients have full bladders during simulation and treatment for better bladder sparing. How this would alter the results we obtained remains to be seen.
Figures 4 and 5 highlight how statistical analyses, average shift vectors, or making shift assumptions based on sampling a portion of the patient's treatment is flawed. Although the total error shift vectors can at times behave predictably, they can also unpredictably change their direction and magnitude during treatment. For example, figure 5d shows how patient 8 has systematic daily total error vectors pointing in one direction during the beginning of treatment followed by about a 90 degree change in direction for the rest of the treatment. In the same figure, although patient 15 has a systematic error through most of the treatment, at the end of treatment the behavior becomes random. Each vector time trend tells a unique story for each patient, highlighting the importance of daily IGRT.
Future areas of research would be to compare bony IGRT versus soft tissue IGRT, similar to what has been done for intact prostate patients , and study the anatomical deformation of the prostate bed.
The overall daily total error shift pattern for these 17 patients simulated with an empty bladder, and treated with CT on rails IGRT was predominantly systematic. Despite this, the temporal vector trends showed complex behaviors and unpredictable changes. These findings highlight the importance of using daily IGRT in post-prostatectomy patients.
Britain Staley and Wanda Yates-Bailey, radiation therapists, for verifying the CT-on-rails procedure description. Darin Noble, medical dosimetrist, for providing the bladder volume measurements.
- Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, et al.: Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005,366(9485):572-578. 10.1016/S0140-6736(05)67101-2View ArticlePubMedGoogle Scholar
- Thompson IM Jr, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, et al.: Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006,296(19):2329-2335. 10.1001/jama.296.19.2329View ArticlePubMedGoogle Scholar
- Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, Storkel S, Willich N, Semjonow A, Souchon R, Stockle M, et al.: Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 2009,27(18):2924-2930. 10.1200/JCO.2008.18.9563View ArticlePubMedGoogle Scholar
- Ost P, Lumen N, Goessaert AS, Fonteyne V, De Troyer B, Jacobs F, De Meerleer G: High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results. Eur Urol 2011,60(4):842-849. 10.1016/j.eururo.2011.04.021View ArticlePubMedGoogle Scholar
- Ost P, Fonteyne V, Villeirs G, Lumen N, Oosterlinck W, De Meerleer G: Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients. Eur Urol 2009,56(4):669-675. 10.1016/j.eururo.2009.05.041View ArticlePubMedGoogle Scholar
- Pinkawa M, Siluschek J, Gagel B, Piroth MD, Demirel C, Asadpour B, Eble MJ: Postoperative radiotherapy for prostate cancer : evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy). Strahlenther Onkol 2007,183(1):23-29. 10.1007/s00066-007-1588-2View ArticlePubMedGoogle Scholar
- Sandhu A, Sethi R, Rice R, Wang JZ, Marcus L, Salem C, Downs T, Parsons JK, Millard F, Pawlicki T, et al.: Prostate bed localization with image-guided approach using on-board imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomy. Radiother Oncol 2008,88(1):20-25. 10.1016/j.radonc.2008.05.009View ArticlePubMedGoogle Scholar
- Koontz BF, Das S, Temple K, Bynum S, Catalano S, Koontz JI, Montana GS, Oleson JR: Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy. Med Dosim 2009,34(3):256-260. 10.1016/j.meddos.2008.10.005View ArticlePubMedGoogle Scholar
- Fiorino C, Foppiano F, Franzone P, Broggi S, Castellone P, Marcenaro M, Calandrino R, Sanguineti G: Rectal and bladder motion during conformal radiotherapy after radical prostatectomy. Radiother Oncol 2005,74(2):187-195. 10.1016/j.radonc.2004.10.002View ArticlePubMedGoogle Scholar
- Kupelian PA, Langen KM, Willoughby TR, Wagner TH, Zeidan OA, Meeks SL: Daily variations in the position of the prostate bed in patients with prostate cancer receiving postoperative external beam radiation therapy. Int J Radiat Oncol Biol Phys 2006,66(2):593-596. 10.1016/j.ijrobp.2006.05.071View ArticlePubMedGoogle Scholar
- Schiffner DC, Gottschalk AR, Lometti M, Aubin M, Pouliot J, Speight J, Hsu IC, Shinohara K, Roach M: Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys 2007,67(2):610-619. 10.1016/j.ijrobp.2006.09.042View ArticlePubMedGoogle Scholar
- Ost P, De Meerleer G, De Gersem W, Impens A, De Neve W: Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy. Int J Radiat Oncol Biol Phys 2011,79(1):188-194. 10.1016/j.ijrobp.2009.10.029View ArticlePubMedGoogle Scholar
- Simpson DR, Einck JP, Nath SK, Sethi RA, Wang JZ, Mundt AJ, Sandhu AP: Comparison of daily cone-beam computed tomography and kilovoltage planar imaging for target localization in prostate cancer patients following radical prostatectomy. Practical Radiation Oncology 2011,1(3):156-162. 10.1016/j.prro.2010.12.002View ArticlePubMedGoogle Scholar
- Ost P, De Gersem W, De Potter B, Fonteyne V, De Neve W, De Meerleer G: A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer. Clin Oncol (R Coll Radiol) 2011,23(5):344-349. 10.1016/j.clon.2011.01.505View ArticleGoogle Scholar
- Kalz J, Sterzing F, Schubert K, Sroka-Perez G, Debus J, Herfarth K: Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy. Strahlenther Onkol 2009,185(4):241-247. 10.1007/s00066-009-1913-zView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.